When PD-1 binds to PD-L1 on the surface of tumor cells, the activation of T cells and their ability to kill tumor cells will be inhibited, which allows tumor cells to cleverly evade the monitoring and clearance of the immune system. The gene discussed is CD274; the disease is neoplasm.